Biosysen Proposes Share Capital Increase

MT Newswires Live
08/05

Biosysen (HKG:1355) is proposing to increase its authorized share capital to HK$100 million divided into 10 billion shares, subject to shareholder approval.

The company will do this by creating an additional 8 billion shares, according to a Wednesday Hong Kong bourse filing.

The move comes to accommodate the potential growth of the company and give it greater flexibility to raise funds in the future.

The company currently has 1.19 billion shares in issue and 806.9 million authorized but unissued.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10